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Abstract
Introduction: HLA-B27 has a modifier effect on the phenotype of multiple diseases, both associated and non-associated
with it. Among these effects, an increased frequency of clinical enthesitis in patients with Rheumatoid Arthritis (RA) has
been reported but never explored again. We aimed to replicate this study with a sensitive and quantitative assessment of
enthesitis by using standardized ultrasonography (US).
Methods: The Madrid Sonography Enthesitis Index (MASEI) was applied to the US assessment of 41 HLA-B27 positive and 41
matched HLA-B27 negative patients with longstanding RA. Clinical characteristics including explorations aimed to evaluate
spondyloarthrtitis and laboratory tests were also done.
Results: A significant degree of abnormalities in the entheses of the patients with RA were found, but the MASEI values, and
each of its components including the Doppler signal, were similar in HLA-B27 positive and negative patients. An increase of
the MASEI scores with age was identified. Differences in two clinical features were found: a lower prevalence of rheumatoid
factor and a more common story of low back pain in the HLA-B27 positive patients than in the negative. The latter was
accompanied by radiographic sacroiliitis in two HLA-B27 positive patients. No other differences were detected.
Conclusion: We have found that HLA-B27 positive patients with RA do not have more enthesitis as assessed with US than
the patients lacking this HLA allele. However, HLA-B27 could be shaping the RA phenotype towards RF seronegativity and
axial involvement.
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Introduction
Research in the genetic component of RA etiology has
experienced a marked progress in recent years with the
identification of a large number of susceptibility loci [1,2].
However, there are still many unsolved questions. Among them
the relative to genotype-phenotype relationships are very prom-
inent. It is expected that genotypes will have an important role in
shaping the RA phenotype and that identification of these
relationships will help manage patients in a personalized manner.
The most established relationship has been the observed between
a large number of RA susceptibility factors and the production of
anti-citrullinated protein antibodies (ACPA). The earlier discov-
ered association of the shared epitope (SE) with severe RA,
including progression of erosive arthritis, seems to be explained by
SE association with ACPA production. Other lines of active
research in this field include the search for genetic factors
modifying progression of erosions [3,4], or response to treatment
[5,6] and of loci associated with ACPA negative patients [7,8].
Some of these studies are focused in RA susceptibility loci [4,6,8],
which are good candidates because of their involvement in the
disease mechanisms. Additional candidates are the genetic factors
associated with related diseases. These loci are also of known
functional relevance and they have the potential of being involved
in subgroups of RA patients sharing clinical characteristics with
the disease where the loci were identified.
One of these candidates is HLA-B27 [9,10,11,12,13]. It is
strongly associated with ankylosing spondylitis (AS) and with other
spondyloarthritis (SpA), but not with RA [14,15]. HLA-B27 has
also modifier effects on the phenotype that have been observed in
its associated diseases and in some non-HLA-B27 associated
diseases. Among the HLA-B27 associated diseases, there are
multiple reports showing earlier disease onset, more involvement
of sacroiliac and spine joints, a higher tendency to chronicity and
more prevalence of back pain in HLA-B27 positive than in
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negative patients [16,17,18,19,20,21]. In addition, non-HLA-B27
associated diseases can be modified to show higher prevalence of
archetypical AS clinical features. For example, HLA-B27 positive
patients with inflammatory bowel disease show an increased
prevalence of sacroiliitis, spondylitis and enthesitis [22,23]. HLA-
B27 also increases the prevalence of sacroiliitis in patients with
familial Mediterranean fever [24]; and of sacroiliitis, inflammatory
back pain and enthesitis in children with Juvenile Idiopatic
Arthritis [25,26]. Therefore, it is not surprising that some
researchers have thought the presence of HLA-B27 could modify
the phenotypes of patients with RA towards resembling SpA.
There have been some reports in this direction [9,10,11,12,13],
but all these studies were done more than a decade ago and none
of their findings have become established. One of these studies
reported an increased prevalence of clinical enthesitis in patients
with early arthritis fulfilling RA criteria [9].
Enthesitis, the inflammation of the entheses, is very prevalent
and relatively specific of all forms of SpA motivating its inclusion
as part of the disease classification criteria [15,27]. Enthesitis is
present in early SpA and, occasionally, it is the unique disease
manifestation for some time. This has lead some authors to
consider enthesitis the primary lesion in this group of diseases [28].
Now we have the possibility to identify early enthesitis when it is
not yet clinically apparent either to patients or to physical
exploration thanks to magnetic resonance imaging and ultraso-
nography (US) [29,30,31,32,33]. This property of US has been
applied to a variety of clinical situations demanding sensitive
evaluation. Examples include SpA with subclinical enthesopathy
[34], recurrent acute anterior uveitis without SpA [35], long term
dialysis [36], and patients with psoriasis without psoriatic arthritis
[36,37], showing in all these cases an increased frequency of
abnormalities. US evaluation has also shown an increased
frequency of abnormalities in patients with RA relative to healthy
controls in spite of the complete absence of clinical enthesitis
[38,39]. Only one of these studies assessed HLA-B27, concerning
recurrent anterior uveitis, and it found that enthesitis was
associated with this HLA allele [35].
Therefore, we have now the opportunity to analyze the
prevalence of enthesitis in RA patients stratified for HLA-B27
status with the sensitivity and accuracy allowed by US. With this
aim, we have selected all available RA patients positive for HLA-
B27 in our hospital and matched RA patients negative for HLA-
B27. The two groups were compared with the Madrid Sonogra-
phy Enthesitis Index (MASEI) [31], focused anamnesis and
physical exploration. No differences in the MASEI or any of its
components were detected. This result excludes a role of HLA-
B27 in the enthesal abnormalities of these patients. However, a
modifier effect of HLA-B27 on the phenotype of the patients with
RA was suggested by its association with RF negative status and a
more frequent story of low back pain.
Materials and Methods
Ethics statement
All patients gave their written informed consent to participate.
Sample collection and the study protocol were approved by the
Comite de Investigacion Clinica de Galicia (Spain).
Selection of patients
DNA and serum samples from patients with RA according to
ACR classification criteria were used [40]. All patients were of
Spanish ancestry and were attending the Rheumatology Unit of
the Hospital Clinico Universitario de Santiago. HLA-B27 positive
patients were selected. Gender, age at disease onset and current
age of these patients was used to select matched HLA-B27
negative patients at a 1:1 ratio. Patients were invited to participate
in the study and they gave their written informed consent. The
rheumatologist and the nurse involved in recruitment and
evaluation of the patients were blind to their HLA-B27 status.
Laboratory studies
Two complementary genotyping reactions were used to
determine the HLA-B27 status (available from the authors upon
request). The first PCR was based on the method of Bon et al.
[41]. It amplifies HLA-B*2701-*2706 alleles, which are the most
common in the Caucasian population and the most associated
with AS. The second PCR used a combination of 3 primers
described by Faner et al. [42]. It amplifies a larger number of
alleles than the first, from HLA-B*2701 to *2724 except for HLA-
B*2718 and HLA-B*2723. PCR amplification was done with a
multiplex PCR system (KAPA2G fast HotStart, Kapa Biosystems,
Woburn, MA). Detection of the PCR products was performed
with single-base extension (SNaPshot Multiplex Kit from Applied
Biosystems, Foster City, CA) using probes targeting a non
polymorphic base. In this way, the most frequents alleles of
HLA-B27 were covered by two PCR. Four samples were positive
only in the second amplification, which is consistent with the low
frequency of the rare alleles in Spain [43].They were excluded
from analysis because of their more uncertain status.
HLA-DBR1 alleles were determined by a sequencing based
typing method (SBT) using the AlleleSEQR HLA-DRB1 Typing
kit (Abbott Diagnostics, Abbott Park, Germany), which includes
bidirectional sequencing of the second exon of DRB1. Ambiguous
samples were additionally sequenced with group-specific primers
(AlleleSEQR HLA-DRB1 GSSP, Abbott). The anti-CCP status of
the patients was determined using the EDIA ACPA Kit (Euro-
Diagnostica, Arnhem, The Netherlands). Quantification and
setting of the cut-off level at 5 units/ml were done according to
the manufacturer’s instructions. RF status was determined by rate
nephelometry with the IMMAGE Immunochemistry Systems
(Beckman Coulter, Ireland), which covers all Ig isotypes.
Clinical and Ultrasound evaluation
Patient history was reviewed and a specific anamnesis of
symptoms and signs characteristic of HLA-B27 associated diseases
was conducted. Physical exploration was done looking for signs of
axial involvement with instruments developed for SpA as the
Schober test, BASDAI and BASFI scores and assessment of the
lateral trunk flexion. A modified Schober test according with Moll
and Wright was used[44]. Inflammatory back pain was defined as
lumbar pain at night or with morning stiffness that does not
improve with rest or that improves with exercise and that persists
for more than a month. Plain antero-posterior pelvic radiographs
were evaluated for the presence of sacroiliitis. This assessment was
independently done by two rheumatologists in a blind form.
In addition, the presence of enthesitis was evaluated by a
rheumatologist experienced in US focused on articular and
periarticular locations and blind to the HLA-B27 status of
patients. A General Electric LogiqQ7 US machine with a 10–14
MHz linear array transducer was used. The power Doppler setting
was standardized with a pulse repetition frequency (PRF) of
500 Hz with a low wall filter and 35–40 dB of gain. The Madrid
Sonography Enthesitis Index (MASEI) was used for quantitative
and standardized assessment [31]. This index evaluates 6 features
in 6 entheses. A value $ 18 has been defined as characteristic of
SpA. The 6 features are enthesis thickness, structure, calcifications,
erosions, bursae and power Doppler signal. The 6 bilaterally
assessed locations are proximal plantar fascia, distal Achilles
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tendon, distal and proximal patellar tendon insertion, distal
quadriceps tendon and brachial triceps tendon.
Statistical analysis
HLA-B27 positive patients with RA were considered cases and
the matched HLA-B27 negative patients were controls. Demo-
graphic, clinical, laboratory, radiographic and ultrasound charac-
teristics were compared between the two groups using Student T
test or the Fisher exact test for contingency tables depending on
the quantitative or qualitative nature of the variables, respectively.
Detailed US results were compared with the Man-Whitney U test
and non-parametric statistics because they showed many zero
values. All analyses were done with Statistica 7.0 (StatSoft, Tulsa,
OK). Differences with P,0.05 were considered statistically
significant.
Results
Analysis of 672 patients with RA identified 65 that were HLA-
B27+, the remaining 607 were HLA-B27- (11 additional patients
showed an uncertain HLA-B27 status and were not included). The
HLA-B27 positive subgroup of patients showed less RF positive
subjects, 50.0 %, than the HLA-B27 negative subgroup 64.6 %
(P = 0.025). Also the ACPA status showed a trend to decreased
prevalence in this subgroup (Table 1). However, there were not
more patients with low titers of ACPA (between 5 and 45 units) in
the HLA-B27 positive (33.3 %) than in the HLA-B27 negative
subgroup (32.8 %). The other characteristics, gender, age at
disease onset, erosive arthritis and carrier status of the SE, were
similar in the two subgroups of patients (Table 1).
A total of 41 HLA-B27 positive patients were available and
willing to participate in the study. One HLA-B27- patient was
selected for each HLA-B27+ patient trying to match them for
gender, age at disease onset and current age. The resulting groups
were very similar not only in the selected variables but also in
other characteristics as height, weight, serology and SE status
(Table 2). During the visit for evaluation one of the patients in the
HLA-B27 positive subgroup was found to have SpA in spite of his
previous classification as RA and was excluded from further
analysis. Specific anamnesis and physical evaluation of the patients
were done blind to their HLA-B27 status. They disclosed a higher
prevalence of low back pain, mechanical or inflammatory, in the
HLA-B27 positive subgroup, 27.5 %, than in the HLA-B27
negative subgroup, 7.5 %, P = 0.037. This difference was similarly
distributed between inflammatory and mechanical pain (Table 3).
No other symptom or evaluation showed differences between the
two patient groups. Specifically there were not differences in
modified Schober’s test, BASDAI or BASFI scores or in the lateral
flexion of the spine (Table 3). A few patients reported a story of
past skin lesions that could correspond to psoriasis but without
differences between the two subgroups.
Two rheumatologists that were blind to the HLA-B27 status of
the patients evaluated plain pelvic radiographs for the presence of
sacroiliitis. Their assessment was fully concordant identifying 2
patients with sacroiliitis. The two were positive for HLA-B27. This
was not significantly different from the result in the HLA-B27
negative subgroup, but we investigated it further. A review of the
two patients with sacroiliitis did not challenge their classification as
RA: the two showed erosive RA and one of them was positive for
ACPA and homozygous for the SE. The two patients had a story
of inflammatory low back pain.
Systematic evaluation of the entheses following the MASEI
procedure (representative images in Figure 1) yielded no differ-
ences between the two subgroups of patients (Table 4). Mean
MASEI values were even nominally lower in the HLA-B27
positive subgroup. Also, the threshold score of 18 proposed as
specific of AS [31], was not discriminating between the two
subgroups: there were 13 patients above this value in the HLA-
B27 positive subgroup and 10 in the HLA-B27 negative subgroup.
In addition, no difference was detected with any of the
components of the index (Table 4). This is specially relevant for
the power Doppler signal (Figure 2) because it has been
differentially associated with SpA relative to other diseases
including RA [39]. But no difference was detected comparing
the whole distribution of values (Table 4), or the percentage of
Table 1. Characteristics of the patients with RA in function of
the HLA-B27 subgroup.
HLA-B27- HLA-B27+ P value
Women % 77.6 (471/607)a 72.3 (47/65) 0.3
Age of disease onset,
mean (SD)
46.3 (14.8) 44.9 (16.7) 0.5
Rheumatoid Factor % b 64.6 (369/571) 50.0 (30/60) 0.025
Anti-CCP % 63.0 (376/597) 50.8 (33/65) 0.05
Anti-CCP median (IQR) c 93.3 (32.82198.0) 67.4 (18.72141.3) 0.3
Carrier SE % 53.3 (286/537) 56.4 (31/55) 0.7
Erosive arthritis % 65.8 (369/561) 61.7 (37/60) 0.5
aNumber with the feature/total number of patients with available information.
bMedian and IQR were 122 (612445) in the HLA-B27- subgroup and 235
(1282366) in the HLA-B27+ subgroup (P = 0.8). This information was available
only for 127 RF+ patients.
cMedian and interquartile range of the anti-CCP positive patients.
doi:10.1371/journal.pone.0058616.t001
Table 2. Characteristics of the patients recruited for detailed
analysis in function of the HLA-B27 subgroup.
HLA-B27- HLA-B27+ P value
Women % 73.2 (30/41)a 80.5 (33/41) 0.6
Age of disease onset, mean
(SD)
41.9 (15.7) 43.9 (17.3) 0.6
Current age, mean (SD) 64.8 (15.2) 64.4 (14.7) 0.9
Weight, mean (SD) 68.8 (12.2) 68.3 (13.7) 0.8
Height, mean (SD) 159.5 (7.8) 158.3 (8.7) 0.5
Ever smoking % 24.4 (10/41) 24.4 (10/41) 1
Rheumatoid factor % 55.0 (22/40) 50.0 (20/40) 0.8
Anti-CCP % 40.0 (16/40) 51.2 (21/41) 0.4
Carrier of SE % 55.0 (22/40) 57.9 (22/38) 0.8
Erosive arthritis % 65.0 (26/40) 53.9 (21/39) 0.4
Biologics % 50.0 (20/40) 60.0 (24/40) 0.5
Anti-TNF b 60.0 (12/20) 45.8 (11/24) 0.4
Rituximab 15.0 (3/20) 16.7 (4/24) 1.0
Abatacept 10.0 (2/20) 20.8 (5/24) 0.4
Tocilizumab 15.0 (3/20) 16.7 (4/24) 1.0
Methotrexate 65.0 (13/20) 83.3 (20/24) 0.2
Leflunomide 20.0 (4/20) 0.0 (0/24) 0.04
aNumber with the feature/total number of patients with available information.
bIncluding Etanercept, Adalimumab and Infliximab.
doi:10.1371/journal.pone.0058616.t002
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positive signals (9/40 in HLA-B-27 positive patients vs. 13/41 in
HLA-B27 negative patients) or the mean values in the patients
showing Doppler signals (4.7 vs. 4.6, in the HLA-B27 positive and
negative patients, respectively). The only associations we identified
were unrelated with the HLA-B27 status: a significant increase of
the MASEI value in men relative to women (not shown), and an
increase of the score with age due to calcifications (not shown).
The two patients with sacroiliitis lacked signs of enthesitis (MASEI
values of 4 and 8).
Discussion
Our analyses have not shown any specific enthesal abnormality
in the HLA-B27 positive patients with RA. The sensitive and
quantitative evaluation allows us to exclude a significant HLA-B27
modifier effect towards enthesitis in the RA patients. However, an
excess of patients in the HLA-B27 positive group referred a story
of low back pain that in two of the patients was associated with
radiographic sacroiliitis. These findings together with a lower
prevalence of RF keep open the possibility of a modifier effect of
the HLA-B27 allele on the phenotype of RA patients, but
excluding the presence of enthesitis.
Our primary aim was to compare the frequency of enthesitis
between HLA-B27 positive and negative patients with RA using
systematic US examination. This imaging technology has shown
sensitivity for detecting a high percentage of SpA patients with
subclinical enthesitis [15,29,30,31,32,33,34,39]. It is applied with
scoring protocols that help differentiate SpA patients from
controls, from subjects that have suffered mechanical injury and
from other forms of inflammatory arthritis [31,32,33]. Specifically,
the MASEI protocol used here has shown high sensitivity and
specificity and it is very comprehensive because it includes
assessment of 6 features in 6 enthesal sites and both grey scales
and power Doppler [31,33]. The assessment of power Doppler is a
distinct advantage of this method over the most commonly used
GUESS procedure for our study because the Doppler signal is the
most specific feature distinguishing SpA from mechanical and RA
enthesal abnormalities [39].
We have found significant abnormalities in the entheses of
patients with RA confirming findings of previous US studies
[38,39,45]. However, no differences were found between HLA-
B27 positive and negative patients, even for components of the
index that are more specific for SpA like the Doppler signal.
Therefore, it is clear that the presence of HLA-B27 does not
induce enthesal pathology in RA patients and that all the
abnormalities found in these patients are produced with indepen-
dence of this genetic factor.
Other interesting aspect of our MASEI results is that only
patients older than 50 years of age showed values over the
threshold identifying patients with AS or SpA [31,33]. Therefore,
our results do not question the specificity of this threshold for early
SpA, which starts most often below this age. An increase of
enthesal abnormalities with age was already shown more than a
decade ago [46]. It was described as independent of the underlying
disease and, as in our study, to be mostly due to calcification.
Two of the other clinical features we have analyzed were
different between HLA-B27 positive and negative patients with
RA. The first was the prevalence of RF, which was less common in
HLA-B27 positive patients. It was accompanied by a trend to
lower prevalence of ACPA. This result could imply either
association of HLA-B27 with RF seronegative RA or misclassifi-
cation of patients. The latter possibility can be reasonably
excluded because we only found a patient with SpA among the
41 that were specifically revised. In addition, the HLA-B27+ RF-
patients were not different in any respect from the HLA-B27- RF-
subgroup. For example, the HLA-B27+RF- and B27-RF- patients
were comparable at percentage of ACPA+, 26.7 % vs. 25.6 %,
erosive arthritis, 51.7 % vs. 45.7 %, or percentage of carriers of
SE, 44.4 % vs. 43.1 %, respectively. This leaves us with the
possibility that HLA-B27 could be a susceptibility factor for RF
seronegative RA. Only studies in additional sample collections will
be needed to clarify this matter.
An increased prevalence of low back pain was also associated
with HLA-B27 in the patients with RA. This outcome from the
anamnesis was combined with the identification of two patients
Table 3. Results of the anamnesis and exploration of
recruited patients in function of the HLA-B27 subgroup.
HLA-B27- HLA-B27+ P value
Back pain % 7.5 (3/40) 27.5 (11/40) 0.037
Inflammatory back pain % 2.5 (1/40) 12.5 (5/40) 0.2
Non-inflammatory back pain %5.0 (2/40) 15.5(6/40) 0. 3
Story of ‘psoriatic’ lesions % 7.3 (3/40) 5.0 (2/40) 1.0
Schober’s test, mean (SD) 3.7 (1.0) 3.8 (1.0) 0.9
Right lateral flexion, mean (SD) 13.2 (4.0) 12.7 (4.4) 0.6
Left lateral flexion, mean (SD) 13.4 (4.3) 11.8 (3.6) 0.1
BASDAI, mean (SD) 4.3 (2.5) 4.6 (2.4) 0.6
BASFI, mean (SD) 2.9 (2.4) 3.4 (2.2) 0.4
Sacroiliitis Rx % 0.0 (0/34)a 5.7 (2/35) 0.3
aNumber with the feature/total number of patients with available information.
doi:10.1371/journal.pone.0058616.t003
Figure 1. Representative images of features detected with US exploration. A) Example of analysis of the Achilles tendon thickness
measured between the two yellow crosses in one patient, and B) Erosion detected in the superior pole of the calcaneous in a different patient.
doi:10.1371/journal.pone.0058616.g001
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with radiographic sacroiliitis among the patients with inflamma-
tory low back pain. The two results are in agreement with the idea
that HLA-B27 could modify RA towards the axial joints. This idea
is supported by previous studies showing association between
sacroiliitis and HLA-B27, both in HLA-27-associated diseases
[17,19,20,21], and in some non-associated diseases [22,23,24,26]
including RA [10,12,13]. In fact, this is the unique association with
HLA-B27 that has been replicated in different RA studies.
However, two previous studies did not found differences in the
sacroiliac joints between HLA-B27 positive and negative patients
with RA [47,48]. These findings should motivate new studies
directed to the analysis of low back pain and to the identification of
sacroiliitis. MRI will be the technology of choice for these studies
because it is very sensitive for incipient changes in the sacroiliac
joints [29], and it could provide more definitive results than
radiography given the small size of the HLA-B27 positive
subgroup.
In relation with the low back pain association, it could be
argued that its presence questions the classification of the patients
as RA. However, this type of reasoning is incompatible with the
aim of our study. When the aim is to identify patients with RA
showing phenotypes resembling SpA, we need to consider
classification of RA before doing any extra analysis and keep this
classification constant along the study.
Conclusions
We have found that HLA-B27 positive patients with RA do not
have more enthesitis as assessed with US than those lacking this
allele. However, these patients referred a more prevalent story of
low back pain and were more often seronegative for RF than the
HLA-B27 negative patients indicating that HLA-B27 could be
shaping the RA phenotype in other directions deserving further
and more focused analysis.
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